Hutch News

Hutch News

Stories tagged 'Effie Petersdorf'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 4, 2018

Increasing access to stem cell transplants; improving survival, QOL for those with scleroderma; biostatistician named chair-elect of AAAS Section on Statistics.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 19, 2016

Fred Hutch receives $50M grant to extend Women’s Health Initiative Clinical Coordinating Center for another five years; Dr. Effie Petersdorf honored for career achievements in transplantation immunogenetics; Fred Hutch President Gary Gilliland receives inaugural Champions for Children Award; Grad student Bish Paul from Kiem Lab among inaugural class of Husky 100.

View story >


Finding a better (mis)match

New way to pair blood stem cell donors with recipients promises to lower risk of potentially devastating transplant side effect

Aug. 28, 2015 | By Susan Keown / Fred Hutch News Service

Soon, many patients coming to Seattle for blood stem cell transplants will have a lower risk of a potentially life-threatening complication thanks to additional genetic testing, which will be built on findings published this month by a team of Fred Hutch researchers led by Dr. Effie Wang Petersdorf.

View story >


Good News at Fred Hutch

Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf

Aug. 13, 2015 | By Fred Hutch staff

Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf

View story >


Appelbaum: $21 million grant renewal for transplantation

Fred Appelbaum, director of Fred Hutch’s Clinical Research Division, and team will continue to refine treatment by reducing barriers to transplantation, improving safety and increasing effectiveness

Nov. 5, 2012 | By Rachel Tompa

View story >


Discovery may reduce GVHD risk in bone marrow transplant patients

Team of scientists led by the Fred Hutchinson Cancer Research Center’s Dr. Effie Petersdorf find previously undetected genetic differences that could better match transplant patients and donors to avoid graft-vs.-host disease.

Sept. 3, 2012 | By Dean Forbes

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.